Breaking News, Collaborations & Alliances

Innovent and Lilly’s Seventh Collaboration Sets Model to Accelerate Pipeline Development

The two companies have had a partnership addressing various patient needs for more than a decade.

Author Image

By: Patrick Lavery

Content Marketing Editor

Innovent Biologics and Eli Lilly and Company are starting a new collaboration to advance novel medicines in immunology and oncology. The collaboration, the seventh between the companies, allows Innovent to accelerate global pipeline development. Innovent Partnerships and Pipeline Innovent, which develops, manufactures, and commercializes medicines for oncologic, autoimmune, cardiovascular, metabolic, ophthalmologic, and other diseases, maintains numerous key partnerships. These include not...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters